TABLE 3.
Univariate Cox analysis for VT recurrence
| HR (95% CI) | P value | |
|---|---|---|
| Age (+5y) | 1.033 (1.000, 1.068) | 0.051 |
| Female | 1.306 (1.031, 1.654) | 0.027 |
| ICM | 0.810 (0.684, 0.959) | 0.015 |
| EF Pre-Ablation (+5%) | 0.871 (0.841, 0.902) | <0.001 |
| NYHA (Ref=I) | ||
| II | 1.721 (1.343, 2.206) | <0.001 |
| III | 2.077 (1.609, 2.682) | <0.001 |
| IV | 2.811 (1.939, 4.075) | <0.001 |
| ICD | 2.361 (1.697, 3.285) | <0.001 |
| CRT | 1.524 (1.268, 1.833) | <0.001 |
| Electrical Storm | 1.583 (1.327, 1.888) | <0.001 |
| ICD Shocks | 1.714 (1.400, 2.099) | <0.001 |
| Syncope | 1.064 (0.779, 1.453) | 0.697 |
| Prior VT Ablation | 1.159 (1.065, 1.261) | <0.001 |
| Prior Heart Surgery | 1.023 (0.842, 1.243) | 0.820 |
| Hypertension | 1.123 (0.937, 1.346) | 0.208 |
| Hyperlipidemia | 1.224 (1.019, 1.470) | 0.030 |
| Atrial Fibrillation | 1.209 (1.002, 1.460) | 0.048 |
| Diabetes Mellitus | 1.343 (1.100, 1.640) | 0.004 |
| Chronic Kidney Disease | 1.308 (1.089, 1.570) | 0.004 |
| Baseline Creatinine | 1.165 (1.052, 1.290) | 0.003 |
| Amiodarone | 1.237 (1.031, 1.484) | 0.022 |
| ≥2 AAD | 1.522 (1.230, 1.883) | <0.001 |
| Beta Blocker | 1.251 (1.005, 1.558) | 0.045 |
| Hemodynamic Support Device | 1.727 (1.203, 2.478) | 0.003 |
| Epi Access | 1.316 (1.093, 1.585) | 0.004 |
| Ablation (Ref=Endo) | ||
| None | 2.272 (0.940, 5.490) | 0.068 |
| Epi | 0.761 (0.503, 1.151) | 0.196 |
| Endo+Epi | 1.237 (0.995, 1.537) | 0.055 |
| Number of VTs Induced | ||
| 1 | 1.031 (0.719, 1.476) | 0.870 |
| 2 | 1.867 (1.310, 2.660) | <0.001 |
| ≥3 | 2.226 (1.582, 3.133) | <0.001 |
| VT Mappability (Ref=All Unmappable) | ||
| Both Unmappable and Mappable | 1.291 (0.972, 1.716) | 0.078 |
| All Mappable | 0.765 (0.610, 0.959) | 0.021 |
| Total Lesion Time | 1.000 (0.997, 1.004) | 0.832 |
| Procedure Time (+15m) | 1.031 (1.020, 1.043) | <0.001 |
| Acute Outcome | ||
| Not Tested | 2.400 (1.689, 3.410) | <0.001 |
| Partial/Failure | 1.845 (1.529, 2.227) | <0.001 |
| Procedural Complications | 1.098 (0.759, 1.590) | 0.619 |